# Slide Insurance Holdings, Inc.: overview

SLDE · Nasdaq · CIK 1886428 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/slde.md) · [Financials](/companies/slde/financials.md) · [Filings](/companies/slde/filings.md) · [Insiders](/companies/slde/insiders.md)

Latest reported revenue: [$386.8m](/filings/0001193125-26-326333.md) for Q2 FY2026, three months to 2026-06-30, from the 10-Q filed Jul 30, 2026 (XBRL us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax, accession 0001193125-26-326333).

## Last eight quarters

| Line item | Unit | period not labelled (2024-09-30) | period not labelled (2024-12-31) | period not labelled (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [200](/filings/0001193125-25-267339.md) | [238 d](/filings/0001193125-26-083277.md) | [282](/filings/0001193125-26-197194.md) | [262](/filings/0001193125-26-326333.md) | [266](/filings/0001193125-25-267339.md) | [347 d](/filings/0001193125-26-083277.md) | [389](/filings/0001193125-26-197194.md) | [387](/filings/0001193125-26-326333.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Net margin | % | [8.8%](/filings/0001193125-25-267339.md) | [31.5% d](/filings/0001193125-26-083277.md) | [32.8%](/filings/0001193125-26-197194.md) | [26.8%](/filings/0001193125-26-326333.md) | [41.8%](/filings/0001193125-25-267339.md) | [49.1% d](/filings/0001193125-26-083277.md) | [35.8%](/filings/0001193125-26-197194.md) | [34.9%](/filings/0001193125-26-326333.md) |
| Diluted EPS | $ per share | [0.15](/filings/0001193125-25-267339.md) | not reported | [0.75](/filings/0001193125-26-197194.md) | [0.56](/filings/0001193125-26-326333.md) | [0.79](/filings/0001193125-25-267339.md) | not reported | [1.02](/filings/0001193125-26-197194.md) | [1.06](/filings/0001193125-26-326333.md) |
| Free cash flow | $m | [115 d](/filings/0001193125-25-267339.md) | [158 d](/filings/0001193125-26-083277.md) | [96.2](/filings/0001193125-26-197194.md) | [253 d](/filings/0001193125-26-326333.md) | [24.5 d](/filings/0001193125-25-267339.md) | [421 d](/filings/0001193125-26-083277.md) | [289](/filings/0001193125-26-197194.md) | [300 d](/filings/0001193125-26-326333.md) |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Operating margin (operating income / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure.

## Last five fiscal years

| Line item | Unit | FY (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: |
| Revenue | $m | [847](/filings/0001193125-26-083277.md) | [1,156](/filings/0001193125-26-083277.md) |
| Gross margin | % | not reported | not reported |
| Operating margin | % | not reported | not reported |
| Net margin | % | [23.8%](/filings/0001193125-26-083277.md) | [38.4%](/filings/0001193125-26-083277.md) |
| Diluted EPS | $ per share | [1.66](/filings/0001193125-26-083277.md) | [3.36](/filings/0001193125-26-083277.md) |
| Free cash flow | $m | [544](/filings/0001193125-26-083277.md) | [795](/filings/0001193125-26-083277.md) |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Operating margin (operating income / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/slde/insiders.md)

| Date | Insider | Role | Transaction | Shares | Reported price | Value | Filing |
| --- | --- | --- | --- | ---: | ---: | ---: | --- |
| 2026-10-22 | [Larson Matthew Paul](/insiders/2114934.md) | Chief Risk Officer, Officer | Sale (S) | 11,150 | $27.55 | $307.2k | [Form 4](/filings/0001193125-26-430460.md) |
| 2026-10-20 | [Larson Matthew Paul](/insiders/2114934.md) | Chief Risk Officer, Officer | Sale (S) | 2,600 | $27.53 | $71.6k | [Form 4](/filings/0001193125-26-428933.md) |

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $98.5m | 5,087,170 |  | Reduced −2,584,720 |
| [VANGUARD PORTFOLIO MANAGEMENT LLC](/funds/2100121.md) | 2026-06-30 | $96.7m | 4,991,909 |  | Added +383,813 |
| [AMERICAN CENTURY COMPANIES INC](/funds/748054.md) | 2026-06-30 | $82.3m | 4,250,123 |  | Added +796,941 |
| [Capital World Investors](/funds/1422849.md) | 2026-06-30 | $58.1m | 2,997,422 |  | Added +81,773 |
| [ARROWSTREET CAPITAL, LIMITED PARTNERSHIP](/funds/1164508.md) | 2026-06-30 | $54.6m | 2,817,330 |  | Added +129,528 |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $44.8m | 2,311,200 |  | Reduced −195,256 |
| [FEDERATED HERMES, INC.](/funds/1056288.md) | 2026-06-30 | $44.3m | 2,285,058 |  | Added +1,917,518 |
| [UBS Group AG](/funds/1610520.md) | 2026-06-30 | $41.7m | 2,152,612 |  | Reduced −376,781 |
| [Hood River Capital Management LLC](/funds/1578177.md) | 2026-06-30 | $36.5m | 1,884,474 |  | Added +631,484 |
| [DME Capital Management, LP](/funds/1489933.md) | 2026-06-30 | $32.7m | 1,686,630 |  | Unchanged |

## Recent filings

[All 217 filings](/companies/slde/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-27 | 16:27 ET | [8-K](/filings/0001193125-26-434282.md) | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.02 Results of operations; 2.03 New direct financial obligation; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-434282 |
| 2026-07-30 | 17:03 ET | [10-Q](/filings/0001193125-26-326333.md) | Quarterly report, period 2026-06-30 | 0001193125-26-326333 |
| 2026-07-28 | 16:28 ET | [8-K](/filings/0001193125-26-321067.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-321067 |
| 2026-07-27 | 16:10 ET | [8-K](/filings/0001193125-26-318080.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-318080 |
| 2026-06-10 | 16:45 ET | [8-K](/filings/0001193125-26-265969.md) | 5.07 Shareholder vote results | 0001193125-26-265969 |
| 2026-06-04 | 08:54 ET | [8-K](/filings/0001193125-26-256573.md) | 8.01 Other events | 0001193125-26-256573 |
| 2026-04-30 | 16:07 ET | [10-Q](/filings/0001193125-26-197194.md) | Quarterly report, period 2026-03-31 | 0001193125-26-197194 |
| 2026-04-28 | 16:17 ET | [DEF 14A](/filings/0001193125-26-187126.md) | Proxy statement, period 2026-04-28 | 0001193125-26-187126 |
| 2026-04-28 | 16:15 ET | [8-K](/filings/0001193125-26-187093.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-187093 |
| 2026-04-28 | 16:10 ET | [8-K](/filings/0001193125-26-187047.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-187047 |

## Latest annual report

[Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001193125-26-083277.md), filed Mar 2, 2026.

## Forecast league

Q3 FY2026, the quarter ended 2026-09-30, locked when the 8-K was accepted. It is scored when the 10-Q or 10-K is ingested. [See the target](/leagues/2026q3/targets/8243de29-40b3-49d2-aa62-4b23115b77bf)

## About the filer

- CIK: 1886428
- Tickers: SLDE
- Exchange: Nasdaq
- SIC code: 6331 Fire, Marine & Casualty Insurance
- State of incorporation: DE
- Filer category: <br>Emerging growth company

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 29, 2026, 16:11 ET. No prices; not investment advice.
